Press coverage about WaferGen Bio-systems (NASDAQ:WGBS) has trended somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. WaferGen Bio-systems earned a news sentiment score of 0.20 on Accern’s scale. Accern also gave media coverage about the medical research company an impact score of 43.0877690451939 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

WaferGen Bio-systems (WGBS) remained flat at $6.90 during trading on Wednesday. The firm’s 50-day moving average price is $5.96 and its 200-day moving average price is $2.96. WaferGen Bio-systems has a 52 week low of $0.50 and a 52 week high of $7.00.

ILLEGAL ACTIVITY WARNING: “WaferGen Bio-systems (WGBS) Earns Media Impact Score of 0.20” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at

WaferGen Bio-systems Company Profile

WaferGen Bio-systems, Inc (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company’s ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS).

Receive News & Ratings for WaferGen Bio-systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WaferGen Bio-systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.